Cargando…
Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past
Rheumatoid arthritis (RA) is a systemic chronic autoimmune inflammatory disease which is mainly characterized by synovitis and results in a severe burden for both the individual and society. To date, the underlying mechanisms of RA are still poorly understood. Pentraxin 3 (PTX3) is a typical long pe...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976587/ https://www.ncbi.nlm.nih.gov/pubmed/33746606 http://dx.doi.org/10.7150/ijms.54787 |
_version_ | 1783667030961946624 |
---|---|
author | Qiu, Cheng Han, Yichao Zhang, Hanwen Liu, Tianyi Hou, Haodong Luo, Dan Yu, Mingzhi Bian, Kai Zhao, Yunpeng Xiao, Xing |
author_facet | Qiu, Cheng Han, Yichao Zhang, Hanwen Liu, Tianyi Hou, Haodong Luo, Dan Yu, Mingzhi Bian, Kai Zhao, Yunpeng Xiao, Xing |
author_sort | Qiu, Cheng |
collection | PubMed |
description | Rheumatoid arthritis (RA) is a systemic chronic autoimmune inflammatory disease which is mainly characterized by synovitis and results in a severe burden for both the individual and society. To date, the underlying mechanisms of RA are still poorly understood. Pentraxin 3 (PTX3) is a typical long pentraxin protein which has been highly conserved during evolution. Meanwhile, functions as well as properties of PTX3 have been extensively studied. Several studies identified that PTX3 plays a predominate role in infection, inflammation, immunity and tumor. Interestingly, PTX3 has also been verified to be closely associated with development of RA. We therefore accomplished an elaboration of the relationships between PTX3 and RA. Herein, we mainly focus on the associated cell types and cognate cytokines involved in RA, in combination with PTX3. This review infers the insight into the interaction of PTX3 in RA and aims to provide novel clues for potential therapeutic target of RA in clinic. |
format | Online Article Text |
id | pubmed-7976587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-79765872021-03-19 Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past Qiu, Cheng Han, Yichao Zhang, Hanwen Liu, Tianyi Hou, Haodong Luo, Dan Yu, Mingzhi Bian, Kai Zhao, Yunpeng Xiao, Xing Int J Med Sci Review Rheumatoid arthritis (RA) is a systemic chronic autoimmune inflammatory disease which is mainly characterized by synovitis and results in a severe burden for both the individual and society. To date, the underlying mechanisms of RA are still poorly understood. Pentraxin 3 (PTX3) is a typical long pentraxin protein which has been highly conserved during evolution. Meanwhile, functions as well as properties of PTX3 have been extensively studied. Several studies identified that PTX3 plays a predominate role in infection, inflammation, immunity and tumor. Interestingly, PTX3 has also been verified to be closely associated with development of RA. We therefore accomplished an elaboration of the relationships between PTX3 and RA. Herein, we mainly focus on the associated cell types and cognate cytokines involved in RA, in combination with PTX3. This review infers the insight into the interaction of PTX3 in RA and aims to provide novel clues for potential therapeutic target of RA in clinic. Ivyspring International Publisher 2021-03-03 /pmc/articles/PMC7976587/ /pubmed/33746606 http://dx.doi.org/10.7150/ijms.54787 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Review Qiu, Cheng Han, Yichao Zhang, Hanwen Liu, Tianyi Hou, Haodong Luo, Dan Yu, Mingzhi Bian, Kai Zhao, Yunpeng Xiao, Xing Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
title | Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
title_full | Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
title_fullStr | Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
title_full_unstemmed | Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
title_short | Perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
title_sort | perspectives on long pentraxin 3 and rheumatoid arthritis: several potential breakthrough points relying on study foundation of the past |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976587/ https://www.ncbi.nlm.nih.gov/pubmed/33746606 http://dx.doi.org/10.7150/ijms.54787 |
work_keys_str_mv | AT qiucheng perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT hanyichao perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT zhanghanwen perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT liutianyi perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT houhaodong perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT luodan perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT yumingzhi perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT biankai perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT zhaoyunpeng perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast AT xiaoxing perspectivesonlongpentraxin3andrheumatoidarthritisseveralpotentialbreakthroughpointsrelyingonstudyfoundationofthepast |